Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2017

2017-08-30
Price :
Published : Aug-2017
No. of Pages : 772
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Gram-Positive Bacterial Infections Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Gram-Positive Bacterial Infections 31
Jun 22, 2017: Motif Bio Invited to Present at Infectious Diseases Conference 31
Clinical Trial Profile Snapshots 32
Appendix 770
Abbreviations 770
Definitions 770
Research Methodology 771
Secondary Research 771
About GlobalData 772
Contact Us 772
Source 772

List of Tables
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Region, 2017* 7
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Gram-Positive Bacterial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Gram-Positive Bacterial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Gram-Positive Bacterial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Gram-Positive Bacterial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Gram-Positive Bacterial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Gram-Positive Bacterial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Gram-Positive Bacterial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 771
Filed in: Pharmaceutical
Publisher : GlobalData